PATENT CLAIM ANALYSIS

Application Number: 15877349
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "136100"]

Abstract:
Isolated monoclonal antibodies that bind to specific epitopes of human tissue factor pathway inhibitor (TFPI) and the isolated nucleic acid molecules encoding them are provided. Pharmaceutical compositions comprising the anti-TFPI monoclonal antibodies and methods of treating deficiencies or defects in coagulation by administration of the antibodies are also provided.

Claim (Index 26):
The isolated monoclonal antibody of  claim 25 , wherein the residue of Kunitz domain 1 comprises one or more residues selected from the group consisting of Asp31, Asp32, Gly33, Pro34, Cys35, Lys36, Cys59, Glu60 and Asn62.

Metadata:
- Claim Count in Document: 40.0
- Percentile: 86.0
- Lexical Diversity: 1.2619
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13721755', '13721802', '13140296', '14775108', '13323691']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8224907603493042
- 35 USC 102 Novelty (BERT): 0.5559998817568355
- Combined Prediction Score: 0.7958416724900574
- Mean Citation Score: 450.195104
- Max Citation Score: 476.53546
- Similarity Product: 315.57892510169506

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test